|
|
Volumn 1, Issue 3, 2003, Pages 251-258
|
|
ATP-sensitive K+ channel openers: old drugs with new clinical benefits for the heart.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
DIAZOXIDE;
GLIBENCLAMIDE;
NICORANDIL;
PINACIDIL;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL BLOCKING AGENT;
VASODILATOR AGENT;
ANIMAL;
CHANNEL GATING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY DISEASE;
DRUG EFFECT;
HUMAN;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REPERFUSION INJURY;
REVIEW;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
CORONARY CIRCULATION;
CORONARY DISEASE;
DIAZOXIDE;
GLYBURIDE;
HUMANS;
ION CHANNEL GATING;
MYOCARDIAL REPERFUSION INJURY;
NICORANDIL;
PINACIDIL;
POTASSIUM CHANNEL BLOCKERS;
POTASSIUM CHANNELS;
RANDOMIZED CONTROLLED TRIALS;
VASODILATOR AGENTS;
|
|
EID: 14844295592
PISSN: 15701611
EISSN: None
Source Type: Journal
DOI: 10.2174/1570161033476646 Document Type: Review |
|
Times cited : (60)
|
|
References (71)
|
